| dc.contributor.advisor | ||
| dc.contributor.advisor | ||
| dc.contributor.author | Chowdhury, Rajdeep | |
| dc.contributor.author | Chowdhury, Shibasish | |
| dc.contributor.author | ||
| dc.contributor.author | Mukherjee, Sudeshna | |
| dc.date.accessioned | 2021-09-27T07:47:10Z | |
| dc.date.available | 2021-09-27T07:47:10Z | |
| dc.date.issued | 2021-01 | |
| dc.identifier.uri | https://cancerci.biomedcentral.com/articles/10.1186/s12935-020-01720-y | |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/2141 | |
| dc.description.abstract | Osteosarcoma (OS) is a malignant tumor of the bone mostly observed in children and adolescents. The current treatment approach includes neoadjuvant and adjuvant chemotherapy; however, drug resistance often hinders therapy in OS patients. Also, the post-relapse survival of OS patients is as low as 20%. We therefore planned to understand the molecular cause for its poor prognosis and design an appropriate therapeutic strategy to combat the disease. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Springer Nature | en_US |
| dc.subject | Biology | en_US |
| dc.subject | Verteporfin | en_US |
| dc.subject | Autophagy | en_US |
| dc.subject | Osteosarcoma cells | en_US |
| dc.title | Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells | en_US |
| dc.type | Article | en_US |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||